Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription 29.10.2018 1 Ann Oncol 2 Ann Surg Oncol 6 BMC Cancer 1 BMC Gastroenterol 7 Cancer 3 Cancer Lett 1 Eur J Cancer 10 Eur J Surg Oncol 3 Gastroenterology 3 Gastrointest Endosc 1 Int J Cancer 1 Int J Oncol 1 J Clin Oncol 6 Oncogene 5 Oncol Rep 1 Oncology 1 Oncology (Williston Park) 4 World J Surg

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Oncol

1. WANG Y, Jones JC, Kipp BR, Grothey A, et al
   Activity of EGFR Antibody in Non-V600 BRAF Mutant Metastatic Colorectal Cancer.
   Ann Oncol. 2018 Oct 26. pii: 5145082. doi: 10.1093.
   PubMed     Text format    
   
   

   
   Ann Surg Oncol

2. SOUWER ETD, Hultink D, Bastiaannet E, Hamaker ME, et al
   The Prognostic Value of a Geriatric Risk Score for Older Patients with Colorectal Cancer.
   Ann Surg Oncol. 2018 Oct 25. pii: 10.1245/s10434-018-6867.
   PubMed     Text format     Abstract available
   
   
3. CREASY JM, D'Angelica MI
   ASO Author Reflections: Primary Tumor Location and Long-Term Survival After Hepatic Resection for Metastatic Colon Cancer.
   Ann Surg Oncol. 2018 Oct 17. pii: 10.1245/s10434-018-6918.
   PubMed     Text format    
   
   

   
   BMC Cancer

4. LAN L, Liu H, Smith AR, Appelman C, et al
   Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins.
   BMC Cancer. 2018;18:809.
   PubMed     Text format     Abstract available
   
   
5. PERTTULA K, Schiffman C, Edmands WMB, Petrick L, et al
   Untargeted lipidomic features associated with colorectal cancer in a prospective cohort.
   BMC Cancer. 2018;18:996.
   PubMed     Text format     Abstract available
   
   
6. ZENG Z, Yang H, Xiao S
   ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.
   BMC Cancer. 2018;18:1020.
   PubMed     Text format     Abstract available
   
   
7. O'GORMAN C, Stack J, O'Ceilleachair A, Denieffe S, et al
   Colorectal cancer survivors: an investigation of symptom burden and influencing factors.
   BMC Cancer. 2018;18:1022.
   PubMed     Text format     Abstract available
   
   
8. YE X, Mo M, Xu S, Yang Q, et al
   The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
   BMC Cancer. 2018;18:1023.
   PubMed     Text format     Abstract available
   
   
9. SPERLICH A, Balmert A, Doll D, Bauer S, et al
   Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer.
   BMC Cancer. 2018;18:998.
   PubMed     Text format     Abstract available
   
   

   
   BMC Gastroenterol

10. HERRERO JM, Vega P, Salve M, Bujanda L, et al
    Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study.
    BMC Gastroenterol. 2018;18:155.
    PubMed     Text format     Abstract available
    
    

    
    Cancer

11. SUBRAMANIAN S, Hoover S, Tangka FKL, DeGroff A, et al
    A conceptual framework and metrics for evaluating multicomponent interventions to increase colorectal cancer screening within an organized screening program.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31686.
    PubMed     Text format     Abstract available
    
    
12. KIM KE, Randal F, Johnson M, Quinn M, et al
    Economic assessment of patient navigation to colonoscopy-based colorectal cancer screening in the real-world setting at the University of Chicago Medical Center.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31690.
    PubMed     Text format     Abstract available
    
    
13. TANGKA FKL, Subramanian S, DeGroff AS, Wong FL, et al
    Identifying optimal approaches to implement colorectal cancer screening through participation in a learning laboratory.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31679.
    PubMed     Text format    
    
    
14. LARA CL, Means KL, Morwood KD, Lighthall WR, et al
    Colorectal cancer screening interventions in 2 health care systems serving disadvantaged populations: Screening uptake and cost-effectiveness.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31691.
    PubMed     Text format     Abstract available
    
    
15. KEMPER KE, Glaze BL, Eastman CL, Waldron RC, et al
    Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in washington state.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31693.
    PubMed     Text format     Abstract available
    
    
16. CHU JN, Choi J, Ostvar S, Torchia JA, et al
    Cost-effectiveness of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer.
    Cancer. 2018 Oct 21. doi: 10.1002/cncr.31795.
    PubMed     Text format     Abstract available
    
    
17. DACUS HLM, Wagner VL, Collins EA, Matson JM, et al
    Evaluation of patient-focused interventions to promote colorectal cancer screening among New York state Medicaid managed care patients.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31692.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

18. GRUNDEMANN C, Huber R
    Chemoprevention with isothiocyanates - From bench to bedside.
    Cancer Lett. 2018;414:26-33.
    PubMed     Text format     Abstract available
    
    
19. BAE WK, Hong CS, Park MR, Sun EG, et al
    TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma.
    Cancer Lett. 2018;415:106-116.
    PubMed     Text format     Abstract available
    
    
20. ZHANG J, Ren P, Xu D, Liu X, et al
    Human UTP14a promotes colorectal cancer progression by forming a positive regulation loop with c-Myc.
    Cancer Lett. 2018 Oct 18. pii: S0304-3835(18)30624.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cancer

21. OGURA A, Akiyoshi T, Yamamoto N, Kawachi H, et al
    Pattern of programmed cell death-ligand 1 expression and CD8-positive T-cell infiltration before and after chemoradiotherapy in rectal cancer.
    Eur J Cancer. 2018;91:11-20.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Surg Oncol

22. SCHMIDT T, Nienhuser H, Kuna C, Klose J, et al
    Prognostic indicators lose their value with repeated resection of colorectal liver metastases.
    Eur J Surg Oncol. 2018;44:1610-1618.
    PubMed     Text format     Abstract available
    
    
23. KLAVER CEL, Wasmann KATGM, Verstegen M, van der Bilt JDW, et al
    Postoperative abdominal infections after resection of T4 colon cancer increase the risk of intra-abdominal recurrence.
    Eur J Surg Oncol. 2018 Oct 18. pii: S0748-7983(18)31435.
    PubMed     Text format     Abstract available
    
    
24. STERPETTI AV
    "A systematic analysis highlighting deficiencies in reported outcomes for patients with stage IV colorectal cancer undergoing palliative resection of the primary tumor" by DP Harji et al.
    Eur J Surg Oncol. 2018 Oct 11. pii: S0748-7983(18)31444.
    PubMed     Text format    
    
    
25. SENORE C, Giovo I, Ribaldone DG, Ciancio A, et al
    Management of Pt1 tumours removed by endoscopy during colorectal cancer screening: Outcome and treatment quality indicators.
    Eur J Surg Oncol. 2018 Oct 16. pii: S0748-7983(18)31428.
    PubMed     Text format     Abstract available
    
    
26. MERTZ-PETERSEN M, Piper TB, Kleif J, Ferm L, et al
    Triage for selection to colonoscopy?
    Eur J Surg Oncol. 2018;44:1539-1541.
    PubMed     Text format     Abstract available
    
    
27. OLTHOF PB, Schnitzbauer AA, Schadde E
    The HPB controversy of the decade: 2007-2017 - Ten years of ALPPS.
    Eur J Surg Oncol. 2018;44:1624-1627.
    PubMed     Text format     Abstract available
    
    
28. BOLMSTRAND B, Nilsson PJ, Holm T, Buchli C, et al
    Patterns of complications following urinary tract reconstruction after multivisceral surgery in colorectal and anal cancer.
    Eur J Surg Oncol. 2018;44:1513-1517.
    PubMed     Text format     Abstract available
    
    
29. HAGEMANS JAW, Rothbarth J, Kirkels WJ, Boormans JL, et al
    Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
    Eur J Surg Oncol. 2018;44:1548-1554.
    PubMed     Text format     Abstract available
    
    
30. HUBERT C, Lucidi V, Weerts J, Dili A, et al
    Impact of biological agents on the prevalence of chemotherapy associated liver injury (CALI): Multicentric study of patients operated for colorectal liver metastases.
    Eur J Surg Oncol. 2018;44:1532-1538.
    PubMed     Text format     Abstract available
    
    
31. PEDERSEN TB, Gocht-Jensen P, Klein MF
    30-day and long-term outcome following salvage surgery for squamous cell carcinoma of the anus.
    Eur J Surg Oncol. 2018;44:1518-1521.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

32. URBAN G, Tripathi P, Alkayali T, Mittal M, et al
    Deep Learning Localizes and Identifies Polyps in Real Time With 96% Accuracy in Screening Colonoscopy.
    Gastroenterology. 2018;155:1069-1078.
    PubMed     Text format     Abstract available
    
    
33. PINSKY PF, Loberg M, Senore C, Wooldrage K, et al
    Number of Adenomas Removed and Colorectal Cancers Prevented in Randomized Trials of Flexible Sigmoidoscopy Screening.
    Gastroenterology. 2018;155:1059-1068.
    PubMed     Text format     Abstract available
    
    
34. HUA F, Shang S, Yang YW, Zhang HZ, et al
    TRIB3 Interacts with Beta-catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Gastroenterology. 2018 Oct 23. pii: S0016-5085(18)35163.
    PubMed     Text format     Abstract available
    
    

    
    Gastrointest Endosc

35. REININK AR, Shaukat A
    Age is not just a number: surveillance colonoscopy is low yield in individuals younger than 50.
    Gastrointest Endosc. 2018;88:724-725.
    PubMed     Text format    
    
    
36. HASSAN C, Senore C, Manes G, Fuccio L, et al
    Diagnostic Yield and Miss Rate of EndoRings in an Organized Colorectal Cancer Screening Program: the SMART (Study Methodology for ADR-Related Technology) Trial.
    Gastrointest Endosc. 2018 Oct 23. pii: S0016-5107(18)33191.
    PubMed     Text format     Abstract available
    
    
37. CRUZ-CORREA M, Gonzalez-Pons MDM
    Reassessing colectomy in young patients with familial adenomatous polyposis.
    Gastrointest Endosc. 2018;88:734-736.
    PubMed     Text format    
    
    

    
    Int J Cancer

38. YANG Y, Cai Q, Shu XO, Steinwandel MD, et al
    Prospective Study of Oral Microbiome and Colorectal Cancer Risk in Low-income and African American Populations.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31941.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

39. LIU SQ, Xu CY, Wu WH, Fu ZH, et al
    Sphingosine kinase 1 promotes the metastasis of colorectal cancer by inducing the epithelialmesenchymal transition mediated by the FAK/AKT/MMPs axis.
    Int J Oncol. 2018 Oct 25. doi: 10.3892/ijo.2018.4607.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

40. GUINTER MA, McCullough ML, Gapstur SM, Campbell PT, et al
    Associations of Pre- and Postdiagnosis Diet Quality With Risk of Mortality Among Men and Women With Colorectal Cancer.
    J Clin Oncol. 2018 Oct 19:JCO1800714. doi: 10.1200/JCO.18.00714.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

41. DIEHL K, Dinges LA, Helm O, Ammar N, et al
    Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.
    Oncogene. 2018;37:39-51.
    PubMed     Text format     Abstract available
    
    
42. SONG C, Liang L, Jin Y, Li Y, et al
    RCC2 is a novel p53 target in suppressing metastasis.
    Oncogene. 2018;37:8-17.
    PubMed     Text format     Abstract available
    
    
43. CHANDRASINGHE P, Cereser B, Moorghen M, Al Bakir I, et al
    Role of SMAD proteins in colitis-associated cancer: from known to the unknown.
    Oncogene. 2018;37:1-7.
    PubMed     Text format     Abstract available
    
    
44. LIU L, Luo C, Luo Y, Chen L, et al
    MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression.
    Oncogene. 2018;37:86-94.
    PubMed     Text format     Abstract available
    
    
45. WEI N, Li J, Fang C, Chang J, et al
    Targeting colon cancer with the novel STAT3 inhibitor bruceantinol.
    Oncogene. 2018 Oct 22. pii: 10.1038/s41388-018-0547.
    PubMed     Text format     Abstract available
    
    
46. WAGNER S, Vlachogiannis G, De Haven Brandon A, Valenti M, et al
    Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.
    Oncogene. 2018 Oct 23. pii: 10.1038/s41388-018-0554.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

47. MUN JG, Kee JY, Han YH, Lee S, et al
    Galla Rhois water extract inhibits lung metastasis by inducing AMPKmediated apoptosis and suppressing metastatic properties of colorectal cancer cells.
    Oncol Rep. 2018 Oct 22. doi: 10.3892/or.2018.6812.
    PubMed     Text format     Abstract available
    
    
48. LU J, Zhang L, Zhou H, Du Z, et al
    Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
    Oncol Rep. 2018;40:887-894.
    PubMed     Text format     Abstract available
    
    
49. TANG B, Liang W, Liao Y, Li Z, et al
    PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway.
    Oncol Rep. 2018 Oct 25. doi: 10.3892/or.2018.6825.
    PubMed     Text format     Abstract available
    
    
50. PENG W, Tan S, Xu Y, Wang L, et al
    LCMS/MS metabolome analysis detects the changes in the lipid metabolic profiles of dMMR and pMMR cells.
    Oncol Rep. 2018;40:1026-1034.
    PubMed     Text format     Abstract available
    
    
51. ZHANG Z, Zhong X, Xiao Y, Chen C, et al
    MicroRNA-296 inhibits colorectal cancer cell growth and enhances apoptosis by targeting ARRB1-mediated AKT activation.
    Oncol Rep. 2018 Oct 18. doi: 10.3892/or.2018.6806.
    PubMed     Text format     Abstract available
    
    

    
    Oncology

52. HAYASHI K, Mitani S, Taniguchi H, Yasui H, et al
    Panitumumab Provides Better Survival Outcomes Compared to Cetuximab for Metastatic Colorectal Cancer Patients Treated with Prior Bevacizumab within 6 Months.
    Oncology. 2018 Oct 25:1-8. doi: 10.1159/000493321.
    PubMed     Text format     Abstract available
    
    

    
    Oncology (Williston Park)

53. WILT C, Le DT
    Integrating Immunotherapy Into Colorectal Cancer Care.
    Oncology (Williston Park). 2018;32:494-8.
    PubMed     Text format     Abstract available
    
    

    
    World J Surg

54. AKIZUKI E, Matsuno H, Satoyoshi T, Ishii M, et al
    Validation of the Japanese Version of the Low Anterior Resection Syndrome Score.
    World J Surg. 2018;42:2660-2667.
    PubMed     Text format     Abstract available
    
    
55. AU KP, Chok KSH, Chan ACY, Dai WC, et al
    Impact of Hepatitis B Carrier Status on the Outcomes of Surgical Treatment of Colorectal Liver Metastases.
    World J Surg. 2018;42:2642-2650.
    PubMed     Text format     Abstract available
    
    
56. VIGANO L, Pedicini V, Comito T, Carnaghi C, et al
    Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases.
    World J Surg. 2018;42:2651-2659.
    PubMed     Text format     Abstract available
    
    
57. HAN J, Hur H, Min BS, Lee KY, et al
    Predictive Factors for Lymph Node Metastasis in Submucosal Invasive Colorectal Carcinoma: A New Proposal of Depth of Invasion for Radical Surgery.
    World J Surg. 2018;42:2635-2641.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: